Serum response factor controls CYLD expression via MAPK signaling pathway
Gang Liang1, Kristofer Ahlqvist, Rajeswararao Pannem
1Department of Laboratory Medicine, Lund University, UMAS, Malmö, Sweden.
Abstract:
Tumor suppressor gene CYLD is a deubiquitinating enzyme which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates. Loss of CYLD in different types of tumors leads to either cell survival or proliferation. In this study we demonstrate that lack of CYLD expression in CYLD-/- MEFs increases proliferation rate of these cells compared to CYLD+/+ in a serum concentration dependent manner without affecting cell survival. The reduced proliferation rate in CYLD+/+ in the presence of serum was due to the binding of serum response factor (SRF) to the serum response element identified in the CYLD promoter for the up-regulation of CYLD levels. The serum regulated recruitment of SRF to the CYLD promoter was dependent on p38 mitogen-activated protein kinase (MAPK) activity. Elimination of SRF by siRNA or inhibition of p38 MAPK reduced the expression level of CYLD and increased cell proliferation. These results show that SRF acts as a positive regulator of CYLD expression, which in turn reduces the mitogenic activation of serum for aberrant proliferation of MEF cells.
Insights
Loss of the tumor suppressor CYLD increases cell proliferation. Serum response factor (SRF) and p38 MAPK regulate CYLD expression, preventing excessive cell growth in MEF cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The CYLD gene functions as a tumor suppressor by deubiquitinating key signaling molecules.
- Loss of CYLD is implicated in tumor development, affecting cell survival and proliferation.
Purpose of the Study:
- To investigate the role of CYLD in mouse embryonic fibroblast (MEF) proliferation.
- To elucidate the molecular mechanisms regulating CYLD expression in response to serum stimulation.
Main Methods:
- Comparison of proliferation rates between CYLD-/- and CYLD+/+ MEFs.
- Analysis of serum response factor (SRF) binding to the CYLD promoter.
- Assessment of p38 mitogen-activated protein kinase (MAPK) involvement.
- Use of siRNA to deplete SRF and pharmacological inhibitors for p38 MAPK.
Main Results:
- CYLD-/- MEFs exhibit increased proliferation compared to CYLD+/+ MEFs in a serum-dependent manner.
- Serum stimulation upregulates CYLD expression in CYLD+/+ MEFs via SRF binding to the CYLD promoter.
- p38 MAPK activity is essential for SRF recruitment to the CYLD promoter.
- SRF depletion or p38 MAPK inhibition reduces CYLD levels and enhances MEF proliferation.
Conclusions:
- SRF acts as a positive regulator of CYLD expression.
- CYLD negatively regulates serum-induced proliferation in MEF cells.
- The SRF-p38 MAPK pathway controls CYLD expression to limit aberrant cell proliferation.
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
Amplifying Signals via Enzymatic Cascade
Cell Signaling in Plants
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...


